Advanced search
Publication Cover
Expert Review of Medical Devices Volume 15, 2018 - Issue 9
Submit an article Journal homepage
1,385
Views
0
CrossRef citations to date
0
Altmetric
Editorial

The coronary sinus Reducer device for refractory chronic angina: rationale, clinical evidence and future perspectives

Rocco A. MontoneDepartment of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, ItalyCorrespondence[email protected]
View further author information
,
Michele RussoDepartment of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, ItalyView further author information
,
Francesco GianniniUnit of Cardiovascular Interventions, IRCCS San Raffaele Scientific Institute, Milan, ItalyView further author information
&
Giampaolo NiccoliDepartment of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, ItalyView further author information
Pages 611-613 | Received 23 May 2018, Accepted 09 Aug 2018, Published online: 04 Sep 2018

References

  • McGillion M, Arthur HM, Cook A, et al. Management of patients with refractory angina: canadian cardiovascular society/canadian pain society joint guidelines. Can J Cardiol. 2012;28(2 Suppl.):S20–S41.
  • Niccoli G, Montone RA, Lanza GA, et al. Angina after percutaneous coronary intervention: the need for precision medicine. Int J Cardiol. 2017;248:14–19.
  • Montalescot G, Sechtem U, Achenbach S, et al. ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European society of cardiology. Eur Heart J. 2013;34:2949–3003.
  • Mannheimer C, Camici P, Chester MR, et al. The problem of chronic refractory angina; report from the ESC joint study group on the treatment of refractory angina. Eur Heart J. 2002;23:355–370.
  • Giannini F, Aurelio A, Jabbour RJ, et al. The coronary sinus reducer: clinical evidence and technical aspects. Expert Rev Cardiovasc Ther. 2017;15:47–58.
  • Beck CS, Leighninger DS. Scientific basis for the surgical treatment of coronary artery disease. J Am Med Assoc. 1955;159:1264–1271.
  • Konigstein M, Giannini F, Banai S. The Reducer device in patients with angina pectoris: mechanisms, indications, and perspectives. Eur Heart J. 2018;39:925–933.
  • Ido A, Hasebe N, Matsuhashi H, et al. Coronary sinus occlusion enhances coronary collateral flow and reduces subendocardial ischemia. Am J Physiol Heart Circ Physiol. 2001;280:H1361–H1367.
  • Banai S, Ben-Muvhar S, Tsehori J, et al. Transcatheter coronary sinus narrowing with the Neovasc Reducer - an alternative treatment approach for patients with disabling angina who are not candidates for revascularization procedures - a preclinical study. Abstract presentation at the 2004 annual conference of the Israel Heart Society.
  • Banai S, Ben Muvhar S, Parikh KH, et al. Coronary sinus reducer stent for the treatment of chronic refractory angina pectoris: a prospective, open-label, multicenter, safety feasibility first-in-man study. J Am Coll Cardiol. 2007;49:1783–1789.
  • Konigstein M, Meyten N, Verheye S, et al. Transcatheter treatment for refractory angina with the coronary sinus Reducer. EuroIntervention. 2014;9:1158–1164.
  • Verheye S, Jolicoeu R, Behan MW, et al. Efficacy of a device to narrow the coronary sinus in refractory angina. N Engl J Med. 2015;372:519–527.
  • Abawi M, Nijhoff F, Doevendans PA, et al. Safety and efficacy of a device to narrow the coronary sinus for the treatment of refractory angina: a single-centre real-world experience. Neth Heart J. 2016;24(9):544–551.
  • Giannini F, Baldetti L, Ponticelli F, et al. Coronary sinus Reducer implantation for the treatment of chronic refractory angina: a single-center experience. JACC Cardiovasc Interv. 2018 Apr 23;11(8):784–792.
  • Baldetti L, Colombo A, Banai S, et al. Coronary sinus reducer non-responders: insights and perspectives. EuroIntervention. 2018;13:1667–1669.
  • Verheye S. REDUCER-1 post-market study and US IDE. Washington (DC): TCT Congress; 2017 Oct 30.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.